Risk behaviour and time as covariates for efficacy of the HIV vaccine regimen ALVAC-HIV (vCP1521) and AIDSVAX B/E: a post-hoc analysis of the Thai phase 3 efficacy trial RV 144.
暂无分享,去创建一个
Jerome H. Kim | D. Stablein | M. Robb | P. Gilbert | S. Rerks-Ngarm | P. Pitisuttithum | S. Nitayaphan | J. Kaewkungwal | J. Chiu | R. Paris | M. Benenson | S. Gurunathan | J. Tartaglia | D. Francis | C. Khamboonruang | P. Thongcharoen | N. Michael | P. Kunasol | P. Morgan | Elizabeth Adams